Reuters logo
BRIEF-Nexstim announces final results from NICHE Phase III trial
February 23, 2017 / 2:43 PM / 8 months ago

BRIEF-Nexstim announces final results from NICHE Phase III trial

Feb 23 (Reuters) - Nexstim Oyj

* Final Results from NICHE Phase III trial presented at the International Stroke Conference

* Says safety results were good with no serious adverse events (SAE) related to the use of Nexstim NBT system

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below